Gracecast Lung Cancer Audio
ASCO 2012 LC Highlights: Dr. Joel Neal on the SELECT Trial of Tarceva (Erlotinib) As Adjuvant Therapy for EGFR Mutation-Positive Advanced NSCLC (audio)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:04:51
- Mas informaciones
Informações:
Sinopsis
Dr. Joel Neal summarizes preliminary results of the SELECT trial of adjuvant Tarceva (erlotinib) for patients with resected EGFR mutation-positive early stage non-small cell lung cancer.
